Daejeon, South Korea

Young-Hee Kho

This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Young-Hee Kho. Retrieved from https://idiyas.com/inventor/young-hee-kho

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Young-Hee Kho: Innovator in Anticancer Research

Introduction

Young-Hee Kho is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of bioscience and biotechnology, particularly in the development of anticancer compositions. His work is vital in the ongoing fight against cancer, showcasing innovative approaches to treatment.

Latest Patents

Young-Hee Kho holds a patent for an anticancer composition comprising obovatol or obovatal. This composition is designed to inhibit the growth of cancer cells and suppress the expression and activity of matrix metalloproteinases (MMPs). The patent highlights the potential of this composition for both the prophylaxis and treatment of cancer, as well as for inhibiting cancer metastasis. He has 1 patent to his name.

Career Highlights

Kho is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research. His work is characterized by a commitment to advancing cancer treatment methodologies through innovative scientific research.

Collaborations

Young-Hee Kho collaborates with notable colleagues, including Byoung-Mog Kwon and Kwang-Hee Son. These partnerships enhance the research efforts and contribute to the development of effective cancer therapies.

Conclusion

Young-Hee Kho's contributions to anticancer research exemplify the importance of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for improving cancer treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…